Amgen (NASDAQ: AMGN), a United States-based biopharmaceutical company, announced on Friday its dividend for the fourth quarter of 2022.
The company has declared dividend of USD1.94 per share.
This dividend will be paid to shareholders of record as of 17 November 2022 on 8 December 2022.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development